InDevR Revenue and Competitors

Boulder, CO USA

Location

$10M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • InDevR's estimated annual revenue is currently $4.6M per year.(i)
  • InDevR's estimated revenue per employee is $77,500
  • InDevR's total funding is $10M.

Employee Data

  • InDevR has 59 Employees.(i)
  • InDevR grew their employee count by 5% last year.

InDevR's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Research and Development OfficerReveal Email/Phone
3
Director Quality AssuranceReveal Email/Phone
4
Chief Operations OfficerReveal Email/Phone
5
Chief Commercial OfficerReveal Email/Phone
6
Director ManufacturingReveal Email/Phone
7
North American Sales DirectorReveal Email/Phone
8
Senior Scientist and Project ManagerReveal Email/Phone
9
Strategic Marketing ManagerReveal Email/Phone
10
Sales Specialist, East CoastReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M35483%$25MN/A
#2
$2M1318%N/AN/A
#3
$3.4M2210%N/AN/A
#4
$68M439-3%N/AN/A
#5
$2M1330%N/AN/A
#6
$4M268%N/AN/A
#7
$2.7M35-10%$23.2MN/A
#8
$5.3M3470%N/AN/A
#9
$1.7M11-8%N/AN/A
#10
$3.1M20-17%N/AN/A
Add Company

What Is InDevR?

InDevR is a global leader in progressive new analytical technologies that enable accelerated development and manufacturing of vaccines and other biotherapeutics. Key products include our VaxArray portfolio of our game-changing multiplexed potency assays for vaccines and the Cypher One system for digital imaging and automated interpretation of hemagglutination assays.

keywords:N/A

$10M

Total Funding

59

Number of Employees

$4.6M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

InDevR News

2022-04-13 - Microarray Market to Witness Huge Growth by 2028 | Takara ...

... Arrayit, Takara Bio, BioGenex, LC Sciences, US Biomax, AXO Science, BioCat, Cepheid, GE Healthcare, InDevR & Qiagen etc.

2019-09-10 - InDevR Raises $7M in Series A Financing

InDevR, Inc., a Boulder, CO-based biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, raised $7m in Series A round of equity financing. Adjuvant Capital made the investment. The company intends to use th ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.1M599%N/A
#2
$11.7M5926%N/A
#3
$7.7M59N/AN/A
#4
$4.6M59-25%$29M
#5
$13.4M6050%$71M